NCT02897661

Brief Summary

Patients with Crohns' disease (CD) are always complicated with malnutrition. Exclusive enteral nutrition (EEN) is an effective treatment to improve nutritional status and induce remission in patients with CD however a reduction in microbiota diversity was the most frequently reported effect of EEN. There was a raised critical question that whether EEN combining microbiota transplantation can bring much more benefits to those CD patients with malnutrition. Fecal microbiota transplantation (FMT) is an effective way of remodeling microbiota. The improved methodology of FMT in our group since 2014 was different from the traditional manual FMT and was recently coined as washed microbiota transplantation (WMT), which is dependent on the automatic facilities and washing process in a laboratory room with biosafety level 3. Importantly, the worse nutritional status might decrease the efficacy of FMT. Therefore, there was a raised critical question that when is the proper time to combine WMT for those CD patients requiring EEN. This trial aimed to explore the timing of WMT in CD patients with malnutrition and assess the efficacy and safety of the strategy using WMT combined with EEN in CD patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

August 14, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 13, 2016

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

July 23, 2020

Status Verified

July 1, 2020

Enrollment Period

4 years

First QC Date

August 14, 2016

Last Update Submit

July 22, 2020

Conditions

Keywords

fecal microbiota transplantationexclusive enteral nutritionwashed microbiota transplantationmalnutrition

Outcome Measures

Primary Outcomes (3)

  • changes in hemoglobin

    Day 8 and day 15

  • changes in albumin and prealbumin in g/L

    Day 8 and day 15

  • changes in lymphocyte count in 10^9/L

    Day 8 and day 15

Secondary Outcomes (1)

  • rate of clinical remission

    day 15

Other Outcomes (1)

  • rate of adverse events

    in 1 month following WMT

Study Arms (2)

Early WMT and EEN

EXPERIMENTAL

WMT (day1), EEN (day1-15)

Procedure: WMTDietary Supplement: EEN

Late WMT and EEN

EXPERIMENTAL

WMT (day8), EEN (day1-15)

Procedure: WMTDietary Supplement: EEN

Interventions

WMTPROCEDURE

Washed microbiota transplantation (WMT) through mid-gut

Early WMT and EENLate WMT and EEN
EENDIETARY_SUPPLEMENT

Exclusive enteral nutrition (EEN) through feeding tube

Early WMT and EENLate WMT and EEN

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients aged 18 to 65 years with active CD, as defined by Harvey-Bradshaw Index (HBI) score \>4;
  • patients accompanied with malnutrition as assessed by Nutritional Risk Screening 2002 (NRS2002) score ≥ 3 or Patient-Generated Subjective Global Assessment (PG-SGA) score ≥ 4;
  • patients with high compliance.

You may not qualify if:

  • accompanying with contraindications of enteral nutrition (EN) such as ileus, active gastrointestinal bleeding and shock;
  • severe comorbidities (e.g., Clostridium difficile infection, diabetes, cancer, cardiopulmonary failure and severe liver and kidney diseases;
  • parenteral infection such as urinary infection, pneumonia, etc;
  • steroids or biologicals use within 6 week;
  • intestinal fibrotic stenosis;
  • patients who are pregnant or going to be pregnant;
  • patients with mental disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, 210011, China

RECRUITING

Related Publications (4)

  • Tjellstrom B, Hogberg L, Stenhammar L, Magnusson KE, Midtvedt T, Norin E, Sundqvist T. Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease. Scand J Gastroenterol. 2012 Dec;47(12):1454-9. doi: 10.3109/00365521.2012.703234. Epub 2012 Sep 28.

    PMID: 23016828BACKGROUND
  • Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P, Huang G, Liu Z, Wu P, Fan Z, Ji G, Wang X, Wu K, Fan D, Zhang F. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol. 2015 Jan;30(1):51-8. doi: 10.1111/jgh.12727.

    PMID: 25168749BACKGROUND
  • Zhang T, Lu G, Zhao Z, Liu Y, Shen Q, Li P, Chen Y, Yin H, Wang H, Marcella C, Cui B, Cheng L, Ji G, Zhang F. Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening. Protein Cell. 2020 Apr;11(4):251-266. doi: 10.1007/s13238-019-00684-8. Epub 2020 Jan 9.

    PMID: 31919742BACKGROUND
  • Xiang L, Yu Y, Ding X, Zhang H, Wen Q, Cui B, Zhang F. Exclusive Enteral Nutrition Plus Immediate vs. Delayed Washed Microbiota Transplantation in Crohn's Disease With Malnutrition: A Randomized Pilot Study. Front Med (Lausanne). 2021 Oct 22;8:666062. doi: 10.3389/fmed.2021.666062. eCollection 2021.

MeSH Terms

Conditions

Crohn DiseaseMalnutrition

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesNutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Faming Zhang, MD; PHD

    Nanjing Medical University

    STUDY CHAIR

Central Study Contacts

Faming Zhang, MD; PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor, Gastroenterology

Study Record Dates

First Submitted

August 14, 2016

First Posted

September 13, 2016

Study Start

August 1, 2016

Primary Completion

August 1, 2020

Study Completion

December 1, 2020

Last Updated

July 23, 2020

Record last verified: 2020-07

Locations